Clinical Trials Logo

Clinical Trial Summary

This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05822193
Study type Observational
Source Inova Medical
Contact Maicon Falavigna, MD, PhD
Phone +5551994408818
Email maicon@inovamedical.com.br
Status Recruiting
Phase
Start date July 21, 2023
Completion date March 1, 2024